Приказ основних података о документу

dc.creatorDragasević, Sanja
dc.creatorStanković, Biljana
dc.creatorSokić-Milutinović, Aleksandra
dc.creatorMilosavljević, Tomica
dc.creatorMilovanović, Tamara
dc.creatorLukić, Snežana
dc.creatorSrzentić Dražilov, Sanja
dc.creatorKlaassen, Kristel
dc.creatorKotur, Nikola
dc.creatorPavlović, Sonja
dc.creatorPopović, Dragan
dc.date.accessioned2022-11-15T14:57:07Z
dc.date.available2019-12-01
dc.date.issued2018
dc.identifier.issn1521-6616
dc.identifier.urihttps://imagine.imgge.bg.ac.rs/handle/123456789/1123
dc.description.abstractBackground and aims: Mucosal gene expression have not been fully enlightened in inflammatory bowel disease (IBD). Aim of this study was to define IL23A, IL17A, IL17F and TLR9 expression in different IBD phenotypes. Methods: Evaluation of mRNA levels was performed in paired non-inflamed and inflamed mucosal biopsies of newly diagnosed 50 Crohn's disease (CD) and 54 ulcerative colitis (UC) patients by quantitative real-time PCR analysis. Results: IL17A and IL17F expression levels were significantly increased in inflamed IBD mucosa. Inflamed CD ileal and UC mucosa showed increased IL23A, while only inflamed CD ileal samples showed increased TLR9 mRNA level. Correlation between analysed mRNAs levels and endoscopic and clinical disease activity were found in UC, but only with clinical activity in CD. Conclusion: Both CD and UC presented expression of Th17-associated genes. Nevertheless, expression profiles between different disease forms varies which should be taken into account for future research and therapeutics strategies.en
dc.publisherAcademic Press Inc Elsevier Science, San Diego
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41004/RS//
dc.relation.isversionofhttps://doi.org/10.1016/j.clim.2018.09.001
dc.rightsembargoedAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceClinical Immunology
dc.subjectInflammatory bowel diseaseen
dc.subjectIL23/IL17/TLR9en
dc.subjectExpression profilingen
dc.titleImportance of TLR9-IL23-1L17 axis in inflammatory bowel disease development: Gene expression profiling studyen
dc.typearticle
dc.rights.licenseBY-NC-ND
dc.citation.epage95
dc.citation.other197(): 86-95
dc.citation.rankM22
dc.citation.spage86
dc.citation.volume197
dc.description.otherThis is the peer reviewed version of the paper: Dragasevic, S., Stankovic, B., Sokic-Milutinovic, A., Milosavljevic, T., Milovanovic, T., Lukic, S., Drazilov, S. S., Klaassen, K., Kotur, N., Pavlovic, S., & Popovic, D. (2018). Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study. Clinical Immunology, 197, 86–95. [https://doi.org/10.1016/j.clim.2018.09.001]
dc.identifier.doi10.1016/j.clim.2018.09.001
dc.identifier.fulltexthttps://imagine.imgge.bg.ac.rs/bitstream/id/11247/Peer_reviewed_version_Importance_of_TLR9-IL23-IL17_axis_in_inflammatory_bowel_disease_development_Gene_expression_profiling_study_2018.pdf
dc.identifier.pmid30193869
dc.identifier.scopus2-s2.0-85053560716
dc.identifier.wos000454372500012
dc.type.versionacceptedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу